Hoffman Michael B's Form 4 filing
Annovis Bio, Inc.ANVS · filed Nov 12, 2025
- Accession no.
- 0001104659-25-109905
- Filed
- Nov 12, 2025
- Trade date
- Oct 28, 2025
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $2.00M. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman Michael BCIK 0001290208 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Common Stock | PPurchaseAcquired | +975,610 | $2.05 | +$2,000,000.5 | 2,455,539 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.